Skip to main content
. Author manuscript; available in PMC: 2014 Jan 9.
Published in final edited form as: J Autism Dev Disord. 2013 Mar;43(3):10.1007/s10803-012-1689-3. doi: 10.1007/s10803-012-1689-3

Table 1. Baseline characteristics across four groups in RUPP Autism Network Risperidone Trials.

Risperidone (N=49) Placebo (N=52) Risperidone (N=49) Risperidone + PT (N=75)
Mean Age (SD) 8.6 (2.97) 9.1 (2.6) 7.50 (2.80) 7.38 (2.21)
N (%) N (%) N (%) N (%)
Males 39 (80) 43 (83) 40 (82) 65 (87)
ASD Diagnosis
Autistic Disorder 49 (100%) 52 (100%) 32 (65.3) 49 (65.3)
PDD-NOS 0 0 13 (26.5) 22 (29.3)
Asperger's 0 0 4 (8.2) 4 (5.3)
IQ*
≥ 70 11 (23.9) 6 (13.3) 23 (46.9) 46 (63.0)
< 70 35 (76.1) 39 (86.7) 26 (53.1) 27 (37.0)
CGI
Moderate 9 (18) 9 (17) 14 (28.6) 25 (33.3)
Marked 27 (55) 28 (57) 19 (38.8) 33(44.0)
Severe 12 (24) 12 (24) 15 (30.6) 17 (22.7)
Extreme 1 (2) 0 1(2.0) 0 (0.0)
Vineland (standard scores) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Communication 45.0 (16.7) 42.0 (14.3) 53.2(19.94) 61.1 (20.95)
Socialization 49.1 (16.6) 47.4 (10.1) 53.5 (14.41) 59.5 (15.01)
Daily Living 40.8 (21.0) 34.0 (15.6) 41.1 (19.81 50.8 (18.49)
ABC
Irritability 26.2 (7.9) 25.5 (6.6) 29.7 (6.1) 29.3 (7.0)
Social Withdrawal 16.4 (8.2) 16.1 (8.7) 17.1 (8.5) 15.2 (9.0)
Stereotypy 10.6 (4.9) 9.0 (4.4) 10.6 (5.5) 7.59 (5.2)
Hyperactivity 31.8 (9.6) 32.3 (8.5) 36.1 (6.9) 35.3 (9.3)
Inappropriate Speech 4.8 (4.1) 6.5 (3.1) 6.37 (4.0) 5.75 (3.4)
CSI
PDD 24.3 (6.9) 23.2 (7.7) 23.2 (7.0) 22.0 (7.7)
Anxiety 14.5 (9.7) 13.8 (7.6) 14.6 (9.5) 17.2 (10.3)
*

IQ missing on 12 subjects; 10 subjects in RUPP 1 and 2 subjects in RUPP 2.